Alzheimer’s study finds racial differences
CHICAGO: Alzheimer’s disease may affect the brain differently in African-Americans than white Americans of European… read more
FDA approves new drug to treat schizophrenia
SILVER SPRING, USA: The U.S. Food and Drug Administration has approved Rexulti (brexpiprazole) tablets to… read more
Safety outcomes of Alzheimer’s IMAGINE extension trial announced
MELBOURNE: Prana Biotechnology has announced the safety outcomes of the IMAGINE Extension study in patients… read more
GIGYF2 mutation in late-onset Parkinson’s disease
UTRECHT: Although in the last two decades there has been considerable progress in understanding the… read more
